Short interest in Cartesian Therapeutics Inc (NASDAQ:RNAC) decreased during the last reporting period, falling from 1.94M to 1.93M. This put 13.35% of the company's publicly available shares short.

Short interest for Cartesian Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Cartesian Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 68.72K shares traded per day, it would take 28.06 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.